Header Logo

Connection

Craig Ceol to Humans

This is a "connection" page, showing publications Craig Ceol has written about Humans.
Connection Strength

0.324
  1. Ceol CJ. Microenvironmental GABA Signaling Regulates Melanomagenesis through Reciprocal Melanoma-Keratinocyte Communication. Cancer Discov. 2023 10 05; 13(10):2128-2130.
    View in: PubMed
    Score: 0.032
  2. Frantz WT, Ceol CJ. Research Techniques Made Simple: Zebrafish Models for Human Dermatologic Disease. J Invest Dermatol. 2022 03; 142(3 Pt A):499-506.e1.
    View in: PubMed
    Score: 0.029
  3. Frantz WT, Ceol CJ. Working together: Heterotypic clusters and collective cell migration in melanoma metastasis. Dev Cell. 2021 10 25; 56(20):2783-2784.
    View in: PubMed
    Score: 0.028
  4. Gramann AK, Frantz WT, Dresser K, Gomes CBF, Lian CG, Deng A, Ceol CJ. BMP Signaling Promotes Neural Crest Identity and?Accelerates Melanoma Onset. J Invest Dermatol. 2021 08; 141(8):2067-2070.e1.
    View in: PubMed
    Score: 0.027
  5. Darp R, Ceol C. Making a melanoma: Molecular and cellular changes underlying melanoma initiation. Pigment Cell Melanoma Res. 2021 03; 34(2):280-287.
    View in: PubMed
    Score: 0.027
  6. Gramann AK, Venkatesan AM, Guerin M, Ceol CJ. Regulation of zebrafish melanocyte development by ligand-dependent BMP signaling. Elife. 2019 12 23; 8.
    View in: PubMed
    Score: 0.025
  7. Venkatesan AM, Vyas R, Gramann AK, Dresser K, Gujja S, Bhatnagar S, Chhangawala S, Gomes CBF, Xi HS, Lian CG, Houvras Y, Edwards YJK, Deng A, Green M, Ceol CJ. Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma. J Clin Invest. 2018 01 02; 128(1):294-308.
    View in: PubMed
    Score: 0.022
  8. Neto A, Ceol CJ. Melanoma-associated GRM3 variants dysregulate melanosome trafficking and cAMP signaling. Pigment Cell Melanoma Res. 2018 01; 31(1):115-119.
    View in: PubMed
    Score: 0.022
  9. Neiswender JV, Kortum RL, Bourque C, Kasheta M, Zon LI, Morrison DK, Ceol CJ. KIT Suppresses BRAFV600E-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling. Cancer Res. 2017 11 01; 77(21):5820-5830.
    View in: PubMed
    Score: 0.021
  10. Painter CA, Ceol CJ. Zebrafish as a platform to study tumor progression. Methods Mol Biol. 2014; 1176:143-55.
    View in: PubMed
    Score: 0.017
  11. Ceol CJ, Houvras Y, Jane-Valbuena J, Bilodeau S, Orlando DA, Battisti V, Fritsch L, Lin WM, Hollmann TJ, Ferr? F, Bourque C, Burke CJ, Turner L, Uong A, Johnson LA, Beroukhim R, Mermel CH, Loda M, Ait-Si-Ali S, Garraway LA, Young RA, Zon LI. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011 Mar 24; 471(7339):513-7.
    View in: PubMed
    Score: 0.014
  12. Ceol CJ, Pellman D, Zon LI. APC and colon cancer: two hits for one. Nat Med. 2007 Nov; 13(11):1286-7.
    View in: PubMed
    Score: 0.011
  13. Smith AO, Frantz WT, Preval KM, Edwards YJK, Ceol CJ, Jonassen JA, Pazour GJ. The Tumor-Associated Calcium Signal Transducer 2 (TACSTD2) oncogene is upregulated in cystic epithelial cells revealing a potential new target for polycystic kidney disease. PLoS Genet. 2024 Dec; 20(12):e1011510.
    View in: PubMed
    Score: 0.009
  14. Qin X, Lam A, Zhang X, Sengupta S, Iorgulescu JB, Ni H, Das S, Rager M, Zhou Z, Zuo T, Meara GK, Floru AE, Kemet C, Veerapaneni D, Kashy D, Lin L, Lloyd K, Kwok L, Smith KS, Nagaraju RT, Meijers R, Ceol C, Liu CT, Alexandrescu S, Wu CJ, Keskin DB, George RE, Feng H. CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness. Sci Adv. 2024 03 15; 10(11):eadh9547.
    View in: PubMed
    Score: 0.008
  15. Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, Bosenberg M, Ceol CJ, Burd CE, Chi P, Herlyn M, Holmen SL, Karreth FA, Kaufman CK, Khan S, Kobold S, Leucci E, Levy C, Lombard DB, Lund AW, Marie KL, Marine JC, Marais R, McMahon M, Robles-Espinoza CD, Ronai ZA, Samuels Y, Soengas MS, Villanueva J, Weeraratna AT, White RM, Yeh I, Zhu J, Zon LI, Hurlbert MS, Merlino G. Melanoma models for the next generation of therapies. Cancer Cell. 2021 05 10; 39(5):610-631.
    View in: PubMed
    Score: 0.007
  16. Iwanaga R, Truong BT, Hsu JY, Lambert KA, Vyas R, Orlicky D, Shellman YG, Tan AC, Ceol C, Artinger KB. Loss of prdm1a accelerates melanoma onset and progression. Mol Carcinog. 2020 09; 59(9):1052-1063.
    View in: PubMed
    Score: 0.006
  17. Wojciechowska S, van Rooijen E, Ceol C, Patton EE, White RM. Generation and analysis of zebrafish melanoma models. Methods Cell Biol. 2016; 134:531-49.
    View in: PubMed
    Score: 0.005
  18. Wojciechowska S, Zeng Z, Lister JA, Ceol CJ, Patton EE. Melanoma Regression and Recurrence in Zebrafish. Methods Mol Biol. 2016; 1451:143-53.
    View in: PubMed
    Score: 0.005
  19. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012 Sep 14; 150(6):1135-46.
    View in: PubMed
    Score: 0.004
  20. Richardson J, Zeng Z, Ceol C, Mione M, Jackson IJ, Patton EE. A zebrafish model for nevus regeneration. Pigment Cell Melanoma Res. 2011 Apr; 24(2):378-81.
    View in: PubMed
    Score: 0.003
  21. Freeman JL, Ceol C, Feng H, Langenau DM, Belair C, Stern HM, Song A, Paw BH, Look AT, Zhou Y, Zon LI, Lee C. Construction and application of a zebrafish array comparative genomic hybridization platform. Genes Chromosomes Cancer. 2009 Feb; 48(2):155-70.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.